Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Surg Oncol Clin N Am. 2013 Jul 30;22(4):10.1016/j.soc.2013.06.003. doi: 10.1016/j.soc.2013.06.003

Figure 3. p53-targeted therapies.

Figure 3

p53 therapies target either mutant p53 (left) or wild type p53 (right). Different therapeutic agents are shown with the year of their first report.